Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
Lancet, 2015 - thelancet.com
Background The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …
18 months of follow-up have been published previously. Herein, we report the final results …
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S RTS - The Lancet, 2015 - cdr.lib.unc.edu
Background—The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …
18 months of follow-up have been published previously. Herein, we report the final results …
[PDF][PDF] Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually …
S RTS - Lancet, 2015 - zoonosis.unam.mx
Background The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …
18 months of follow-up have been published previously. Herein, we report the final results …
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
H Tinto, U D'Alessandro, H Sorgho, I Valea… - …, 2015 - tobias-lib.ub.uni-tuebingen.de
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and
children in Africa: final results of a phase 3, individually randomised, controlled trial Efficacy …
children in Africa: final results of a phase 3, individually randomised, controlled trial Efficacy …
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S RTS, EV Macete, P Alonso, J Sacarlal… - Lancet, 2015, vol. 386 …, 2015 - diposit.ub.edu
BACKGROUND: The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine
during 18 months of follow-up have been published previously. Herein, we report the final …
during 18 months of follow-up have been published previously. Herein, we report the final …
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S RTS - Lancet, 2015 - europepmc.org
Background The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …
18 months of follow-up have been published previously. Herein, we report the final results …
[PDF][PDF] Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually …
S RTS - Lancet, 2015 - 132.248.200.6
Background The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …
18 months of follow-up have been published previously. Herein, we report the final results …
[PDF][PDF] Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually …
S RTS - Lancet, 2015 - nitag-resource.org
Background The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …
18 months of follow-up have been published previously. Herein, we report the final results …
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S RTS - Lancet, 2015 - edoc.unibas.ch
The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during 18 months of
follow-up have been published previously. Herein, we report the final results from the same …
follow-up have been published previously. Herein, we report the final results from the same …
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S RTS - Lancet, 2015 - researchonline.lshtm.ac.uk
BACKGROUND: The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine
during 18 months of follow-up have been published previously. Herein, we report the final …
during 18 months of follow-up have been published previously. Herein, we report the final …